| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3990804 | Journal of Thoracic Oncology | 2018 | 9 Pages |
Abstract
Our data suggest polymorphic variations of drug metabolic gene were associated with response and toxicity of cisplatin/gemcitabine-based therapy and progression-free survival of patients with advanced NSCLC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Vienna PhD, Irene PhD, Lorenza PhD, Vincenzo MD, Marialuisa MD, Rita MD, Daniela MSc, Francesca Romana PhD, Antonella PhD, Annamaria PhD, Elisa PhD, Maurizio MD, Lucio MD,